Colombia's INVIMA Timelines: A Pure Global Deep Dive on Medical Device Registration Delays and How to Navigate the LATAM Market

Colombia is one of Latin America's most promising MedTech markets, but gaining access requires navigating the complex regulatory landscape of its authority, INVIMA. While official timelines suggest a straightforward process, the reality on the ground can be quite different, with unexpected delays impacting launch plans and revenue forecasts.

In this episode, we uncover the real-world timelines for medical device registration in Colombia. We explore a case study of a European orthopedic company that planned for an 8-month approval for their Class IIb device, only to be delayed by an additional five months due to a request for information regarding the applicability of their clinical data, costing them significant time and market opportunity.

Key Takeaways:
* What are INVIMA's official review timelines for different device classes?
* Is there a fast-track 'automatic' registration process for certain devices?
* Why do official timelines often not match reality in Colombia?
* What is the single most common reason for significant registration delays?
* How does a request for additional information (RFI) impact your approval clock?
* Are there specific Spanish language requirements for technical dossiers that companies often miss?
* How does your existing FDA or CE Mark approval impact your submission to INVIMA?
* Why is having a local legal representative a non-negotiable first step?

At Pure Global, we specialize in transforming these regulatory challenges into market opportunities. With our local expertise in Colombia and advanced AI tools, we streamline the INVIMA registration process, helping you avoid common pitfalls and accelerate your market access. Contact us to learn how we can help you at [email protected] or visit https://pureglobal.com/.